Opioid Use Disorder Market Size, Share, Trends, Growth Outlook

Opioid Use Disorder Market is estimated to increase at a growth rate of 11.2% CAGR over the forecast period from 2024 to 2030.

The global Opioid Use Disorder Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Drug (Buprenorphine, Methadone, Naltrexone), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies & Stores).

An introduction to Opioid Use Disorder Market in 2024

Addressing the complex challenges of opioid addiction and substance use disorder, the Opioid Use Disorder Market offers a spectrum of pharmacological and behavioral interventions for the prevention, treatment, and recovery from opioid dependence and addiction. Opioid use disorder (OUD) treatments include medications such as methadone, buprenorphine, and naltrexone, alongside counseling, psychotherapy, and medication-assisted treatment (MAT) programs providing comprehensive support and rehabilitation services for individuals with OUD. The market's growth is driven by the opioid epidemic, increasing demand for addiction treatment services, and policy efforts to expand access to evidence-based interventions and harm reduction strategies addressing OUD prevalence and associated health disparities.

Opioid Use Disorder market Trend: Rise in Adoption of Medication-Assisted Treatment (MAT)

A significant trend in the Opioid Use Disorder market is the increasing adoption of Medication-Assisted Treatment (MAT) approaches. MAT combines behavioral therapy with medications such as methadone, buprenorphine, and naltrexone to treat opioid dependence effectively. With growing recognition of MAT's effectiveness in reducing opioid cravings, preventing relapse, and improving treatment outcomes, there's a shift towards integrating MAT into standard care protocols for opioid use disorder (OUD). This trend reflects a broader emphasis on evidence-based practices and harm reduction strategies in addressing OUD, driving demand for MAT medications and related services in healthcare settings.

Opioid Use Disorder market Driver: Escalation of Opioid Epidemic and Public Health Concerns

The primary driver in the Opioid Use Disorder market is the escalation of the opioid epidemic and associated public health concerns. Opioid misuse, addiction, and overdose have reached epidemic proportions globally, leading to significant morbidity, mortality, and societal costs. As governments, healthcare organizations, and communities grapple with the devastating impact of the opioid crisis, there's a heightened urgency to expand access to evidence-based treatment options for individuals with OUD. This pressing need to address the opioid epidemic drives demand for medications, therapies, and support services tailored to individuals with OUD, propelling market growth in the OUD treatment sector.

Opioid Use Disorder market Opportunity: Expansion of Telemedicine and Digital Health Solutions

One potential opportunity in the Opioid Use Disorder market is the expansion of telemedicine and digital health solutions for OUD treatment and support services. Telemedicine platforms offer a convenient and accessible way for individuals with OUD to access medication management, counseling, and support remotely, especially in underserved or rural areas with limited access to traditional healthcare services. Additionally, digital health tools such as smartphone apps, online support groups, and teletherapy sessions provide opportunities for ongoing monitoring, engagement, and relapse prevention in OUD recovery. By leveraging telemedicine and digital health solutions, healthcare providers and technology companies can expand the reach of OUD treatment services, improve patient engagement, and enhance outcomes for individuals affected by OUD.

Opioid Use Disorder Market Market Segmentation

By Drug
Buprenorphine
-Bunavail
-Sublocade
-Suboxone
-Zubsolv
-Others
Methadone
Naltrexone
By Route of Administration
Oral
Parenteral
By Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies & Stores

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Opioid Use Disorder Market Companies

Alkermes
Camurus AB
Collegium Pharmaceutical
Hikma Pharmaceuticals PLC
Indivior PLC
MediciNova Inc
Omeros Corp
Orexo AB
Teva Pharmaceutical Industries Ltd
Titan Pharmaceuticals Inc

Reasons to Buy the Opioid Use Disorder Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Opioid Use Disorder Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Opioid Use Disorder Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Opioid Use Disorder Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Opioid Use Disorder Market Size Outlook, $ Million, 2021 to 2030
3.2 Opioid Use Disorder Market Outlook by Type, $ Million, 2021 to 2030
3.3 Opioid Use Disorder Market Outlook by Product, $ Million, 2021 to 2030
3.4 Opioid Use Disorder Market Outlook by Application, $ Million, 2021 to 2030
3.5 Opioid Use Disorder Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Opioid Use Disorder Industry
4.2 Key Market Trends in Opioid Use Disorder Industry
4.3 Potential Opportunities in Opioid Use Disorder Industry
4.4 Key Challenges in Opioid Use Disorder Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Opioid Use Disorder Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Opioid Use Disorder Market Outlook by Segments
7.1 Opioid Use Disorder Market Outlook by Segments, $ Million, 2021- 2030
By Drug
Buprenorphine
-Bunavail
-Sublocade
-Suboxone
-Zubsolv
-Others
Methadone
Naltrexone
By Route of Administration
Oral
Parenteral
By Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies & Stores

8 North America Opioid Use Disorder Market Analysis and Outlook To 2030
8.1 Introduction to North America Opioid Use Disorder Markets in 2024
8.2 North America Opioid Use Disorder Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Opioid Use Disorder Market size Outlook by Segments, 2021-2030
By Drug
Buprenorphine
-Bunavail
-Sublocade
-Suboxone
-Zubsolv
-Others
Methadone
Naltrexone
By Route of Administration
Oral
Parenteral
By Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies & Stores

9 Europe Opioid Use Disorder Market Analysis and Outlook To 2030
9.1 Introduction to Europe Opioid Use Disorder Markets in 2024
9.2 Europe Opioid Use Disorder Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Opioid Use Disorder Market Size Outlook by Segments, 2021-2030
By Drug
Buprenorphine
-Bunavail
-Sublocade
-Suboxone
-Zubsolv
-Others
Methadone
Naltrexone
By Route of Administration
Oral
Parenteral
By Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies & Stores

10 Asia Pacific Opioid Use Disorder Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Opioid Use Disorder Markets in 2024
10.2 Asia Pacific Opioid Use Disorder Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Opioid Use Disorder Market size Outlook by Segments, 2021-2030
By Drug
Buprenorphine
-Bunavail
-Sublocade
-Suboxone
-Zubsolv
-Others
Methadone
Naltrexone
By Route of Administration
Oral
Parenteral
By Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies & Stores

11 South America Opioid Use Disorder Market Analysis and Outlook To 2030
11.1 Introduction to South America Opioid Use Disorder Markets in 2024
11.2 South America Opioid Use Disorder Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Opioid Use Disorder Market size Outlook by Segments, 2021-2030
By Drug
Buprenorphine
-Bunavail
-Sublocade
-Suboxone
-Zubsolv
-Others
Methadone
Naltrexone
By Route of Administration
Oral
Parenteral
By Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies & Stores

12 Middle East and Africa Opioid Use Disorder Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Opioid Use Disorder Markets in 2024
12.2 Middle East and Africa Opioid Use Disorder Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Opioid Use Disorder Market size Outlook by Segments, 2021-2030
By Drug
Buprenorphine
-Bunavail
-Sublocade
-Suboxone
-Zubsolv
-Others
Methadone
Naltrexone
By Route of Administration
Oral
Parenteral
By Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies & Stores

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Alkermes
Camurus AB
Collegium Pharmaceutical
Hikma Pharmaceuticals PLC
Indivior PLC
MediciNova Inc
Omeros Corp
Orexo AB
Teva Pharmaceutical Industries Ltd
Titan Pharmaceuticals Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Drug
Buprenorphine
-Bunavail
-Sublocade
-Suboxone
-Zubsolv
-Others
Methadone
Naltrexone
By Route of Administration
Oral
Parenteral
By Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies & Stores